相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
Heather Torrey et al.
SCIENCE SIGNALING (2017)
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
Heather Torrey et al.
SCIENCE SIGNALING (2017)
PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
Bradley M. Haverkos et al.
BLOOD (2017)
Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
Claudio G. Brunstein et al.
BLOOD (2016)
TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment
Antonio Pierini et al.
BLOOD (2016)
Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells
Mathieu Leclerc et al.
BLOOD (2016)
Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion
Martin Chopra et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Suppressive activity of human regulatory T cells is maintained in the presence of TNF
Bruno Zaragoza et al.
NATURE MEDICINE (2016)
Immune checkpoint blockade in hematologic malignancies
Philippe Armand
BLOOD (2015)
Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2
Alexander Ungewickell et al.
NATURE GENETICS (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Blockade of TNF-α signaling benefits cancer therapy by suppressing effector regulatory T cell expansion
Li-Yuan Chang et al.
ONCOIMMUNOLOGY (2015)
Effector T Cells Boost Regulatory T Cell Expansion by IL-2, TNF, OX40, and Plasmacytoid Dendritic Cells Depending on the Immune Context
Audrey Baeyens et al.
JOURNAL OF IMMUNOLOGY (2015)
Regulatory T-cell depletion in donor lymphocyte infusions for haematological malignancies: long-term outcomes from a prospective study
Sebastien Maury et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
Alana A. Kennedy-Nasser et al.
CLINICAL CANCER RESEARCH (2014)
Potential limitations of IL-2 administration for the treatment of experimental acute graft-versus-host disease
Louis Perol et al.
IMMUNOLOGY LETTERS (2014)
Associations between functional TNFR2 196 M/R polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis
Gwan Gyu Song et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+Tregs within the tumor microenvironment
Chindu Govindaraj et al.
CLINICAL IMMUNOLOGY (2013)
TNFR2 expression on CD25(hi)FOXP3(+) T cells induced upon TCR stimulation of CD4T cells identifies maximal cytokine-producing effectors
Chindu Govindaraj et al.
FRONTIERS IN IMMUNOLOGY (2013)
TNF signaling drives myeloid-derived suppressor cell accumulation
Xueqiang Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Raising the Bar: The Curative Potential of Human Cancer Immunotherapy
Steven A. Rosenberg
SCIENCE TRANSLATIONAL MEDICINE (2012)
Immune reconstitution is preserved in hematopoietic stem cell transplantation coadministered with regulatory T cells for GVHD prevention
Aline Gaidot et al.
BLOOD (2011)
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
Claudio G. Brunstein et al.
BLOOD (2011)
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia
Marc Buyse et al.
BLOOD (2011)
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Mauro Di Ianni et al.
BLOOD (2011)
Tumor necrosis factor receptor cross-talk
Petrus J. W. Naude et al.
FEBS JOURNAL (2011)
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
John Koreth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs
Yenkel Grinberg-Bleyer et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
TNF receptor 2 pathway: drug target for autoimmune diseases
Denise Faustman et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
CD4+CD25+ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation
Sebastien Maury et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
TNF RECEPTOR 2, NOT TNF RECEPTOR 1, ENHANCES MESENCHYMAL STEM CELL-MEDIATED CARDIAC PROTECTION FOLLOWING ACUTE ISCHEMIA
Megan L. Kelly et al.
SHOCK (2010)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells:: Applicability to tumor-infiltrating T regulatory cells
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2007)
A functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case-control study and a meta-analysis
Takahiko Horiuchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Tumor necrosis factor receptor 2 M196R polymorphism in rheumatoid arthritis and osteoarthritis:: relationship with sTNFR2 levels and clinical features
Edith Oregon-Romero et al.
RHEUMATOLOGY INTERNATIONAL (2006)
Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-verus-host-disease by inhibiting activation/differentiation of pathogenic T cells
A Trenado et al.
JOURNAL OF IMMUNOLOGY (2006)
Tumour necrosis factor-α receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab
M Pierik et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
M Edinger et al.
NATURE MEDICINE (2003)
Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects
P Reddy et al.
BLOOD (2003)
Recipient-type specific CD4(+)CD25(+) regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia
A Trenado et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease
JL Cohen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation
P Hoffmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality
PA Taylor et al.
BLOOD (2002)
Cytokines -: Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation
Y Ishikawa et al.
BONE MARROW TRANSPLANTATION (2002)
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells:: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance
S Sakaguchi et al.
IMMUNOLOGICAL REVIEWS (2001)
Quantifying the frequency of alloreactive T cells in vivo: New answers to an old question
EJ Suchin et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
